Overview

Iron Supplementation and Intestinal Health

Status:
Recruiting

Trial end date:
2025-07-31

Target enrollment:

Participant gender:

Summary

This is a randomized double-blinded study of enteral iron supplementation in Very Low Birth Weight infants. The subjects will be randomized into low dose (2 mg/kg/day) and high dose (6 mg/kg/day) of daily iron supplementation. The primary outcomes are intestinal health including microbiome, inflammation, and barrier function.

Phase:

Phase 4

Details

Lead Sponsor:

University of South Florida

Collaborator:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Iron